Board on Health Sciences Policy & Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union 
Regulatory Processes for Rare Disease Drugs in the United States and European Union [EPUB ebook] 
Flexibilities and Collaborative Opportunities

Ondersteuning
Hoes van Board on Health Sciences Policy & Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union: Regulatory Processes for Rare Disease Drugs in the United States and Europea

Rare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe. Congress called on the U.S. Food and Drug Administration (FDA) to sponsor a National Academies study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. The resulting report provides recommendations for enhancing and promoting rare disease drug development by improving engagement with people affected by a rare disease, advancing regulatory science, and fostering collaboration between FDA and the European Medicines Agency.

€43.84
Betalingsmethoden
Koop dit e-boek en ontvang er nog 1 GRATIS!
Taal Engels ● Formaat EPUB ● Pagina’s 386 ● ISBN 9780309726580 ● Editor Carolyn K. Shore & Carson W. Smith ● Uitgeverij National Academies Press ● Gepubliceerd 2024 ● Downloadbare 3 keer ● Valuta EUR ● ID 10044764 ● Kopieerbeveiliging Adobe DRM
Vereist een DRM-compatibele e-boeklezer

Meer e-boeken van dezelfde auteur (s) / Editor

33.253 E-boeken in deze categorie